P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
批准号:
7768494
负责人:
Arthur M. BUCHBERG
金额:
$23.89万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2012-02-28
关键词:
AffectApoptosisApoptoticAttenuatedBindingBiological AssayBreastBreast CarcinomaCell Cycle ArrestCell Cycle CheckpointCell Cycle RegulationCellsCellular StressCo-ImmunoprecipitationsDNA DamageDNA Microarray ChipElectrophoretic Mobility Shift AssayElementsGene AmplificationGene Expression ProfilingGene TargetingGenesGenetic TranscriptionGenotoxic StressGoalsHumanKnock-outMDM2 geneMalignant NeoplasmsMeasuresMediatingN-terminalNeuroblastomaOvarianPPM1D genePathway interactionsPatternPhosphorylationPhosphotransferasesPlayProtein p53Protein phosphataseReactionReporter GenesResearch PersonnelRoleSignal TransductionStressTP53 geneTestingTimeTranscription CoactivatorTranscriptional ActivationTransfectionTransgenesTumor Cell LineTumor Suppressor ProteinsWestern Blottingabstractingbasechemotherapeutic agentchromatin immunoprecipitationin vivoneoplastic cellnovel therapeutic interventionovarian neoplasmp53 Signaling Pathwayp53-binding proteinprogramspromoterresponsetranscription factortumor
中文摘要
PPM1D改变P53介导的Gl/M检查点调控
P53肿瘤抑制蛋白是一种序列特异性转录因子,调节细胞对
基因毒性应激和其他形式的细胞应激。PPM1D(正式名称为WIPL)在转录上被激活
以P53依赖的方式对基因毒性应激做出反应。它编码一种针对应激诱导的蛋白质磷酸酶
P38MAPK,它破坏了p38MAPK-P53信号通路。这与心脏的变化有关
P53蛋白N末端的磷酸化模式。N-末端磷酸化是P53蛋白表达的重要途径
起到转录因子的作用。我们和其他人已经证明,强迫外源表达PPM ID会减弱
对DNA损伤剂的细胞凋亡反应。降低人体肿瘤细胞中的PPM1D
表达它是由于基因扩增增强了对化疗药物的凋亡反应。这与以下内容相关
促凋亡基因Bax表达水平的变化。本项目的目标是阐明
以及PPM1D在调节p53转录活性中所起的作用。
PPM1D阻断p38MAPK-P53信号通路影响P53介导的反应基因转录
参与细胞周期检查点控制和/或细胞凋亡。具体目标如下:1)确定是否
PPM ID介导的p38MAPK-P53信号中断改变P53蛋白与P53反应之间的相互作用
下游靶基因的元件。2)确定PPMID是否介导了p38MAPK-P53信号的中断
改变P53蛋白与转录共激活因子的相互作用。3)鉴定和鉴定其基因
PPM ID介导的p38MAPK-p53信号通路的破坏改变了p38MAPK-P53的表达。
摘要:PPM1D是P53网络中的一个新成员,目前我们对其知之甚少。PPM1D
在含有野生型p53基因的人乳腺、卵巢和神经母细胞瘤中,基因经常被扩增。这
项目将提供有关PPM1D在细胞周期涉及的P53网络中所起作用的新信息
控制和细胞凋亡,并阐明这一作用的机制基础。
英文摘要
P53-Mediated Gl/M Checkpoint Controls Altered by PPM1D
The p53 tumor suppressor protein is a sequence-specific transcription factor that modulates the response of cells to
genotoxic stress and other forms of cellular stress. PPM1D (formally called Wipl) is transcriptionally-activated in
response to genotoxic stress in a p53-dependent manner. It encodes a protein phosphatase that targets the stress induced
kinase p38MAPK which disrupts the p38MAPK-p53 signalingpathway. This is correlated with alterations in the
pattern of N-terminal phosphorylation on p53 protein. N-terminal phosphorylation is important for p53 protein to
function as a trariscriptional factor. We and others have shown that forced exogenous expression of PPM ID attenuates
the apoptotic response to DNA-damaging agents. Decreasing PPM1D in human tumor cells that constitutively over
express it due to gene amplification enhances the apoptotic response to chemotherapeutic agents. This is correlated with
changes,in the level of expression of the pro-apoptotic Bax gene.The goal of this project is to elucidate the mechanistic
basis and the role that PPM1D plays in modulatingthe transcriptional activity of p53.The hypothesis to be tested is that
disruption of the p38MAPK-p53 signaling pathway by PPM1D affects p53-mediated transcription of responsive genes
involved in cell cycle checkpoint control and/or apoptosis. The Specific Aims are the following: 1) To determine if
PPM ID-mediated disruptionof p38MAPK-p53 signalingalters the interaction between p53 protein and p53-responsive
elements of downstream target genes. 2) To determine if PPMID-mediated disruptionof p38MAPK-p53 signaling
alters the interaction of p53 protein with transcriptional coactivators. 3) To identify and characterize genes whose
expression is altered by PPM ID-mediated disruption of the p38MAPK-p53 signaling pathway.
Lay Abstract: PPM1D is a new player in the p53 network about which we know very little at present. The PPM1D
gene is often amplified in human breast, ovarian and neuroblastoma tumors that harbor a wild type p53 gene. This
project will provide new informationregarding the role that PPM1D plays in the p53 network involved in cell cycle
control and apopotosis and elucidate the mechanistic basis for this action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lab Animal
-
批准号:8302936
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2011
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Lab Animal
-
批准号:8084093
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2010
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Sensitized screen to identify cooperating genes involved in pancreatic cancer
-
批准号:7660263
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2009
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7002695
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:7163452
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6633389
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6712794
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6124693
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6513550
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE TRANSFORMING PROPERTIES OF THE MEIS1 GENE FAMILY
-
批准号:6377140
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2000
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7568858
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6101894
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
-
批准号:7350950
-
项目类别:
-
资助金额:$23.89万
-
财政年份:1999
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6268994
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6102571
-
项目类别:
-
资助金额:$24.92万
-
财政年份:1998
-
负责人:Arthur M. BUCHBERG
-
依托单位:
THE MURINE ALL-1 GENE--TUMORIGENESIS AND DEVELOPMENT
-
批准号:6237085
-
项目类别:
-
资助金额:$24.09万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
NOVEL ONCOGENES IN VIRUS INDUCED MYELOID TUMORS
-
批准号:6236418
-
项目类别:
-
资助金额:$26.88万
-
财政年份:1997
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099261
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:3202730
-
项目类别:
-
资助金额:$17.63万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
INVOLVEMENT OF THE EVI-2 LOCUS IN MYELOID LEUKEMIA
-
批准号:2099260
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1993
-
负责人:Arthur M. BUCHBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: